Unaudited Results For 30.09.2024
Filed with BSE · · 10 pages · English
November 14, 2024 Sub: Outcome of Board Meeting held on 14.11.2024 We wish to inform you that the Board of Directors of the Company in their Board Meeting held today i.e., 14.11.2024, inter alia, considered and approved the following: 1. Unaudited Standalone and consolidated financial results for the half year ended 30.09.2024. 2. Took note of the Limited Review Report issued by the statutory audi
Earlier from Vanta Bioscience
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2024
- Vanta Bioscience Ltd. Press Release Nov 11 2024
- Board Meeting Intimation for Approval Of Un-Audited Financial Statements Of 30.09.2024 And Conversion Of Unsecured Loans Into Equity Shares
- Vanta Bioscience Ltd. Press Release Nov 07 2024
- Reply To Clarification On Price Movement Sought By BSE
Later from Vanta Bioscience
- Board Meeting Intimation for Conversion Of Unsecured Loans Into Equity Shares
- Vanta Bioscience Ltd. Press Release Dec 03 2024
- Board Meeting Outcome for Outcome Of Board Meeting Held On 06.12.2024
- Vanta Bioscience Ltd. Press Release Dec 06 2024
- Notice Of EGM To Be Held On 04.01.2025
Follow Vanta Bioscience into a list and get an email when it puts out news.
Follow Vanta Bioscience